Patent ID: 8440660
Filing Date: 2013-05-14
Classification: A61P,C07D

Abstract:
1. A method for treating a disease related to the glucocorticoid receptor selected from the group consisting of obesity, enteritis, asthma, atopic dermatitis, allergic rhinitis, Alzheimer's disease, hypertension, hypercalcemia, hyperinsulinemia, hyperlipidemia, a homeostasis-related disease causing an abnormality of neuro-immune-endocrine balance and glaucoma, the method comprising administering a pharmacologically effective amount of a compound represented by the following formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient to a patient: wherein R 1 represents a hydrogen atom or a lower alkyl group; R R R R X represents —C(O)—, —C(O)NR R Y represents a lower alkylene group; Z represents a chalcogen atom; p represents 0, 1, 2 or 3, in the case where p is 2 or 3, each R